Global Multiple Sclerosis Market By Types (Clinically isolated syndrome (CIS), Relapse-Remitting MS (RRMS), Primary Progressive MS (PPMS), Secondary Progressive MS (SPMS)), By Diagnosis (Blood Test, Spinal Tap, MRI , Evoked Potential Tests, Optical Coherence Tomography (OCT) Others)By Route of Administration(Subcutaneous, Oral, Intravenous) By Treatment (Corticosteroids, Disease-modifying therapies (DMTs) Plasma exchange (plasmapheresis) Injectable, Oral treatments, Infusions treatments, Physical Therapy, Others) By End Users( Hospitals, Speciality Clinics, Homecare, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030